MetLife Investment Management’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$728K Buy
22,485
+571
+3% +$14.7K ﹤0.01% 1699
2026
Q1
$402K Hold
21,914
﹤0.01% 1852
2025
Q4
$345K Sell
21,914
-1,202
-5% -$21.5K ﹤0.01% 1971
2025
Q3
$448K Buy
+23,116
New +$451K ﹤0.01% 1858
2025
Q2
Sell
-23,365
Closed -$572K 2778
2025
Q1
$572K Sell
23,365
-243
-1% -$6.24K ﹤0.01% 1662
2024
Q4
$565K Buy
23,608
+999
+4% +$31.7K ﹤0.01% 1739
2024
Q3
$958K Hold
22,609
0.01% 1413
2024
Q2
$1.16M Buy
22,609
+3,312
+17% +$188K 0.01% 1267
2024
Q1
$1.21M Sell
19,297
-716
-4% -$48.7K 0.01% 1198
2023
Q4
$1.5M Sell
20,013
-1,382
-6% -$98.9K 0.01% 1096
2023
Q3
$1.82M Hold
21,395
0.01% 940
2023
Q2
$2.33M Sell
21,395
-1,434
-6% -$136K 0.02% 879
2023
Q1
$1.89M Hold
22,829
0.01% 930
2022
Q4
$2.35M Hold
22,829
0.02% 837
2022
Q3
$2.42M Sell
22,829
-404
-2% -$44.3K 0.02% 795
2022
Q2
$2.55M Sell
23,233
-1,891
-8% -$187K 0.02% 799
2022
Q1
$2.62M Buy
25,124
+8,945
+55% +$929K 0.02% 882
2021
Q4
$1.98M Sell
16,179
-686
-4% -$76.2K 0.02% 871
2021
Q3
$1.94M Hold
16,865
0.02% 870
2021
Q2
$1.64M Sell
16,865
-1,680
-9% -$146K 0.01% 949
2021
Q1
$1.37M Hold
18,545
0.01% 993
2020
Q4
$1.27M Sell
18,545
-1,578
-8% -$103K 0.01% 1027
2020
Q3
$1.18M Sell
20,123
-1,569
-7% -$82.6K 0.01% 954
2020
Q2
$981K Buy
21,692
+1,849
+9% +$88.4K 0.01% 1047
2020
Q1
$1.15M Hold
19,843
0.02% 844
2019
Q4
$1.24M Hold
19,843
0.01% 989
2019
Q3
$1.14M Sell
19,843
-1,749
-8% -$96.8K 0.01% 1006
2019
Q2
$1.17M Hold
21,592
0.01% 1035
2019
Q1
$1.02M Hold
21,592
0.01% 1076
2018
Q4
$1.22M Hold
21,592
0.01% 950
2018
Q3
$1.18M Hold
21,592
0.01% 1056
2018
Q2
$1.26M Hold
21,592
0.01% 931
2018
Q1
$1.23M Hold
21,592
0.01% 933
2017
Q4
$1.06M Buy
+21,592
New +$984K 0.01% 1009

Other funds holding AMN

MetLife Investment Management's AMN Position: Q2 2026 in Review

MetLife Investment Management increased its AMN Healthcare (AMN) stake by 2.6% in Q2 2026, buying an estimated $14.7K and bringing the position to 22,485 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

MetLife Investment Management first reported a position in AMN in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.62M in Q1 2022. 284 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

  • MetLife Investment Management held 22,485 shares of AMN Healthcare worth $728K as of Q2 2026.
  • MetLife Investment Management bought 571 AMN Healthcare shares in Q2 2026, an estimated $14.7K.
  • AMN Healthcare made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1699 holding.
  • MetLife Investment Management first reported a position in AMN Healthcare in Q4 2017 and has held it in 34 quarters since.
  • MetLife Investment Management's AMN Healthcare position peaked at $2.62M in Q1 2022.
  • 284 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.